about
The elementome of calcium-based urinary stones and its role in urolithiasisUrine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasisMultiple microcrystal deposition within a family.Effects of citrate and NaCl on size, morphology, crystallinity and microstructure of calcium phosphates obtained from aqueous solutions at acidic or near-neutral pH.2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.Hypocitraturia in patients with urolithiasis.Aggregation of Calcium Phosphate and Oxalate Phases in the Formation of Renal Stones.Kidney stones in primary hyperoxaluria: new lessons learnt.Elemental Content of Calcium Oxalate Stones from a Canine Model of Urinary Stone DiseaseIdiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a historyIdiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.Intranephronic calculosis in rats: an ultrastructural study.Studying inhibition of calcium oxalate stone formation: an in vitro approach for screening hydrogen sulfide and its metabolites.Antiurolithiatic Activity of Extract and Oleanolic Acid Isolated from the Roots of Lantana camara on Zinc Disc Implantation Induced Urolithiasis.Bryophyllum pinnatum Leaf Extracts Prevent Formation of Renal Calculi in Lithiatic Rats.Physicochemical mechanisms of stone formation.Dietary zinc intake and kidney stone formation: evaluation of NHANES III.Mechanisms of Stone Formation.Idiopathic calcium oxalate urolithiasis and endogenous oxalate production.Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.Compositional analysis of various layers of upper urinary tract stones by infrared spectroscopy.Biomimetic synthesis of struvite with biogenic morphology and implication for pathological biomineralization.Renal stone disease--investigative aspectsStructure--activity relationship of inhibitors of hydroxyapatite formation.Creatinine, calcium, citrate and acid-base in spinal cord injured patients.Kidney stones. Medical management and newer options for stone 'removal'.Prediction of renal crystalline size distributions in space using a PBE analytic model. 2. Effect of dietary countermeasures.Calculosis in paraplegia.Calcium and magnesium metabolism during long-term treatment with thiazides.Citrate excretion in spinal cord patients.Applied Pathology for Interventions of Coronary Chronic Total Occlusion.
P2860
Q26786250-DB201C18-253C-40F3-89E8-B7A4D687707FQ28362644-6223E498-6CEA-47E7-9B56-161156F424CDQ33556056-663613B7-C578-4575-8A47-E72002409108Q34257747-613B7495-54C5-4935-8CE2-384FF324ABEFQ34620181-4227F1E9-B174-49A8-892E-2E71E74EFC70Q34798110-542D8532-1FFC-42F4-8C7B-0BA84BF3D07AQ34927076-58E0F7BA-B917-40E4-AAA6-1AE72F43FB7EQ34935451-12B7C28A-AD95-4596-B84F-7A60E74896C7Q35661301-77895F72-32DE-49F2-89DB-078447BBA632Q35674510-132B64A1-53E2-42A4-94B8-BAEEAA1AA2DAQ35674522-E7FE864C-072E-4588-BC7F-8B4EE5E548B8Q35863965-F2B45713-4CEC-402A-BC5C-B2821A3C56DEQ36575951-D2E66E2C-B984-4DF2-978D-2089331C8D9CQ36882717-3F155B78-E0FA-47B5-A6B1-B4EC54F52054Q37739735-C27D6658-13DC-46A3-A847-C50D599F3136Q39032471-79955E37-8E23-4FA3-8C4D-9F1098609960Q39506858-31B653D6-8AFB-4C6D-9FDA-C32DF059C69EQ40198027-3B7EBA33-BB53-43AC-AD36-E7F5C1FB31BCQ41133065-3714BA2B-5D42-41A2-9FC1-2F4B413F7CCBQ41193178-4B23EDA1-D809-4B3E-8C1C-461171DFD105Q41623733-0F00CB06-B712-4574-AAE1-92936F7E9ED9Q41851239-A38EA4DC-4948-4E3A-87B5-98683368AE98Q42583964-0F89BF25-3C56-41B7-8DC9-25C60D3159F6Q42880387-9DAE984D-AB78-47BC-9296-F6F085221C2DQ44388803-EB822BEE-6583-4F31-B1C2-448FF750EE55Q45192899-644856ED-4502-4704-B3DA-86AA496704E9Q47297952-44845CF7-4AA3-4D3D-A2CD-69F035756815Q50941144-B64652E0-D890-44F2-A19B-DBC0DC10FDC1Q51656121-0D35E7BC-FF44-4D80-B803-4AD107C8A643Q52470993-B6271DAE-0D75-4AB9-BCB4-32833D1D45A7Q54863191-F39D2358-065A-476C-AD5E-15855525A8A5
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Inhibitors and promoters of stone formation.
@en
Inhibitors and promoters of stone formation.
@nl
type
label
Inhibitors and promoters of stone formation.
@en
Inhibitors and promoters of stone formation.
@nl
prefLabel
Inhibitors and promoters of stone formation.
@en
Inhibitors and promoters of stone formation.
@nl
P356
P1433
P1476
Inhibitors and promoters of stone formation.
@en
P2093
P2888
P304
P356
10.1038/KI.1978.54
P407
P577
1978-05-01T00:00:00Z